Nicholas Hannah

Parkville, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Editorial: The Next Frontier in Alcohol-Associated Liver Disease: Integrating Social Determinants of Health Into Risk Stratification and Care Delivery.

Editorial: The Next Frontier in Alcohol-Associated Liver Disease: Integrating Social Determinants of Health Into Risk Stratification and Care Delivery.

Journal: Alimentary pharmacology & therapeutics

Published: August 25, 2026

Re-Evaluating Hepatocellular Carcinoma Diagnosis in Fontan-Associated Liver Disease: Are We Treating the Right Patients at the Right Time?

Re-Evaluating Hepatocellular Carcinoma Diagnosis in Fontan-Associated Liver Disease: Are We Treating the Right Patients at the Right Time?

Journal: Journal of gastroenterology and hepatology

Published: April 25, 2026

Hepatic hydrothorax as a manifestation of decompensated cirrhosis: An update on current management and future directions.

Hepatic hydrothorax as a manifestation of decompensated cirrhosis: An update on current management and future directions.

Journal: World journal of hepatology

Published: June 06, 2025

Prostate-Specific Membrane Antigen (PSMA) PET/CT in the Detection and Diagnosis of Hepatocellular Carcinoma (HCC): A Systematic Review and Meta-Analysis.

Prostate-Specific Membrane Antigen (PSMA) PET/CT in the Detection and Diagnosis of Hepatocellular Carcinoma (HCC): A Systematic Review and Meta-Analysis.

Journal: Cancers

Published: October 16, 2024

Patient Reported Outcomes in Primary Sclerosing Cholangitis: An Australian Perspective.

Patient Reported Outcomes in Primary Sclerosing Cholangitis: An Australian Perspective.

Journal: Alimentary pharmacology & therapeutics

Published: August 19, 2024

Initial Trans-Arterial Chemo-Embolisation (TACE) Is Associated with Similar Survival Outcomes as Compared to Upfront Percutaneous Ablation Allowing for Follow-Up Treatment in Those with Single Hepatocellular Carcinoma (HCC) ≤ 3 cm: Results of a Real-World Propensity-Matched Multi-Centre Australian Cohort Study.

Initial Trans-Arterial Chemo-Embolisation (TACE) Is Associated with Similar Survival Outcomes as Compared to Upfront Percutaneous Ablation Allowing for Follow-Up Treatment in Those with Single Hepatocellular Carcinoma (HCC) ≤ 3 cm: Results of a Real-World Propensity-Matched Multi-Centre Australian Cohort Study.

Journal: Cancers

Published: August 06, 2024

Different Patterns of Care and Survival Outcomes in Transplant-Centre Managed Patients with Early-Stage HCC: Real-World Data from an Australian Multi-Centre Cohort Study.

Different Patterns of Care and Survival Outcomes in Transplant-Centre Managed Patients with Early-Stage HCC: Real-World Data from an Australian Multi-Centre Cohort Study.

Journal: Cancers

Published: May 05, 2024

Improved Survival Outcomes with Surgical Resection Compared to Ablative Therapy in Early-Stage HCC: A Large, Real-World, Propensity-Matched, Multi-Centre, Australian Cohort Study.

Improved Survival Outcomes with Surgical Resection Compared to Ablative Therapy in Early-Stage HCC: A Large, Real-World, Propensity-Matched, Multi-Centre, Australian Cohort Study.

Journal: Cancers

Published: November 01, 2023

Surveillance MRI is associated with improved survival in patients with primary sclerosing cholangitis.

Surveillance MRI is associated with improved survival in patients with primary sclerosing cholangitis.

Journal: Hepatology communications

Published: October 29, 2023

Letter: time to consider Pneumocystis jirovecii pneumonia prophylaxis in treatment of autoimmune hepatitis.

Letter: time to consider Pneumocystis jirovecii pneumonia prophylaxis in treatment of autoimmune hepatitis.

Journal: Alimentary pharmacology & therapeutics

Published: March 14, 2023

Outpatient albumin infusions reduce hospitalizations and improve outcomes in decompensated cirrhosis: A real-world cohort study.

Outpatient albumin infusions reduce hospitalizations and improve outcomes in decompensated cirrhosis: A real-world cohort study.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: March 09, 2023

Serum ammonia does not guide management and is overutilised in patients with cirrhosis in hospital settings.

Serum ammonia does not guide management and is overutilised in patients with cirrhosis in hospital settings.

Journal: Internal medicine journal

Published: August 03, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026